Detalhe da pesquisa
1.
Liposomal amphotericin for secondary prophylaxis: A systematic review and meta-analysis.
J Oncol Pharm Pract
; : 10781552241241317, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720564
2.
Delayed Diagnosis of Chronic Necrotizing Granulomatous Skin Lesions due to TAP2 Deficiency.
J Clin Immunol
; 43(1): 217-228, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36227411
3.
Efficacy of Hemoperfusion in Severe and Critical Cases of COVID-19.
Blood Purif
; 52(1): 8-16, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580567
4.
One-step and sequential SARSCOV-2 polymerase chain reaction tests would not work every time.
J Clin Lab Anal
; 36(2): e24226, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34997789
5.
Brucellosis in transplant recipients: A systematic review.
Transpl Infect Dis
; 23(4): e13604, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743545
6.
Promising effects of atorvastatin on mortality and need for mechanical ventilation in patients with severe COVID-19; a retrospective cohort study.
Int J Clin Pract
; 75(9): e14434, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34080261
7.
Lupus Anticoagulant Is Associated with Critical Cases and High Mortality in COVID-19: A Literature Review.
Tanaffos
; 22(1): 53-60, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37920325
8.
A Case of Fingolimod-associated Cryptococcal Meningitis.
Curr HIV Res
; 20(4): 337-342, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35770404
9.
Garcin syndrome in a case of acquired immunodeficiency syndrome.
Clin Case Rep
; 10(10): e6476, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36267829
10.
Early recovery of botulism: one decade of experience.
Clin Toxicol (Phila)
; 59(7): 628-632, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33156710
11.
An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.
Int Immunopharmacol
; 99: 107916, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224994
12.
Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial.
Int Immunopharmacol
; 99: 107969, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34273635
13.
An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.
Trials
; 21(1): 880, 2020 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106183